Tower Research Capital LLC (TRC) - AMBRX BIOPHARMA INC ownership

AMBRX BIOPHARMA INC's ticker is AMAM and the CUSIP is 02290A102. A total of 17 filers reported holding AMBRX BIOPHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of AMBRX BIOPHARMA INC
ValueSharesWeighting
Q3 2023$2,702
+1384.6%
235
-98.9%
0.00%
-100.0%
Q1 2023$18220,440
+681233.3%
0.01%
Q4 2022$03
-92.9%
0.00%
Q3 2022$0420.00%
Other shareholders
AMBRX BIOPHARMA INC shareholders Q3 2022
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 11,304,573$100,836,79127.58%
COMMODORE CAPITAL LP 4,803,447$42,846,7476.52%
VR Adviser, LLC 3,298,577$29,423,3075.74%
Cormorant Asset Management, LP 8,500,000$75,8204.99%
Ghost Tree Capital, LLC 250,000$2,230,0000.66%
TOMS Capital Investment Management LP 1,000,000$8,920,0000.55%
Artal Group S.A. 702,291$6,2640.37%
Fosun International Ltd 249,190$2,222,7750.21%
D. E. Shaw & Co., Inc. 3,933,552$35,087,2840.04%
FARALLON CAPITAL MANAGEMENT LLC 361,000$3,220,1200.02%
View complete list of AMBRX BIOPHARMA INC shareholders